Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamphetamine versus methylphenidate for initial ADHD dose titration
ACTRN12616000569404Phase 4Completed
- Sponsor
- Nepean Blue Mountains Local Health District
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dextroamphetamine and methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Nepean Blue Mountains Local Health District. Started Oct 2016; status: completed.
02
Drugs
dextroamphetaminemethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on ACTRN12616000569404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000569404.